Discover
TLSI
TriSalus Life Sciences, Inc.
4.46
2 x 3.28
2 x 5.63
bid
ask
-
0.09
1.98%
2 @ 04:00 PM
4.46 +0.00 (0.00%)
| Ytd | -36.10% | |
| 1y | -13.40% |
4.34
day range
4.62
2.20
52 week range
7.95
| Open | 4.52 | Prev Close | 4.55 | Low | 4.34 | High | 4.62 | Mkt Cap | 273.92M |
| Vol | 201.02K | Avg Vol | 460.66K | EPS | -1.42 | P/E | N/A | Forward P/E | -3.50 |
| Beta | 0.50 | Short Ratio | 2.38 | Inst. Own | 17.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.90 | 200-d Avg | 4.83 | 1yr Est | 11.64 |
| Income Statement | |||
| Total Revenue | 8.90M | ||
| Revenues (USD) | 8.90M | ||
| Cost of Revenue | 1.23M | ||
| Gross Profit | 7.67M | ||
| Operating Expenses | 16.08M | ||
| Research and Development Expense | 3.22M | ||
| Selling, General and Administrative Expense | 12.86M | ||
| Operating Income | -8.41M | ||
| Interest Expense | 1.44M | ||
| Income Tax Expense | 4.00K | ||
| Net Income | 1.54M | ||
| Net Income Common Stock | 1.54M | ||
| Net Income Common Stock (USD) | 1.54M | ||
| Consolidated Income | 1.54M | ||
| Earnings per Basic Share | 0.03 | ||
| Earnings per Basic Share (USD) | 0.03 | ||
| Earnings per Diluted Share | 0.03 | ||
| Earning Before Interest & Taxes (EBIT) | 2.98M | ||
| Earning Before Interest & Taxes (USD) | 2.98M | ||
| Weighted Average Shares | 51.54M | ||
| Weighted Average Shares Diluted | 52.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 56.55M | ||
| Cash and Equivalents (USD) | 56.55M | ||
| Trade and Non-Trade Receivables | 5.22M | ||
| Current Assets | 68.14M | ||
| Property, Plant & Equipment Net | 2.77M | ||
| Total Assets | 70.98M | ||
| Debt Current | 218.00K | ||
| Total Debt | 34.49M | ||
| Current Liabilities | 11.79M | ||
| Debt Non-Current | 34.27M | ||
| Total Liabilities | 58.17M | ||
| Accumulated Retained Earnings (Deficit) | -329.04M | ||
| Shareholders Equity | 12.81M | ||
| Shareholders Equity (USD) | 12.81M | ||
| Assets Non-Current | 2.84M | ||
| Total Debt (USD) | 34.49M | ||
| Inventory | 3.78M | ||
| Liabilities Non-Current | 46.39M | ||
| Trade and Non-Trade Payables | 4.23M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 166.00K | ||
| Net Cash Flow from Financing | 42.39M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 35.76M | ||
| Capital Expenditure | -141.00K | ||
| Issuance (Purchase) of Equity Shares | 42.66M | ||
| Issuance (Repayment) of Debt Securities | -272.00K | ||
| Net Cash Flow from Investing | -141.00K | ||
| Net Cash Flow from Operations | -6.48M | ||
| Share Based Compensation | 2.47M | ||